Quick Takeaways
- MANGROVE PARTNERS IM, LLC filed SCHEDULE 13G for Anebulo Pharmaceuticals, Inc. Common Stock (ANEB).
- Disclosed ownership: 6.2%.
- Date of event: 31 Dec 2024.
MANGROVE PARTNERS IM, LLC - 31 Dec 2024 SCHEDULE 13G Report for Anebulo Pharmaceuticals, Inc. Common Stock (ANEB)
- Filing Manager
- MANGROVE PARTNERS IM, LLC
- Reporting Manager
- Mangrove Partners IM, LLC
- Symbol
- ANEB
- Shares outstanding
- 41,061,008 shares
- Disclosed Ownership
- 2,525,252 shares
- Ownership
- 6.2%
- Form type
- SCHEDULE 13G
- Filing time
- 17 Mar 2025, 16:51:40 UTC
- Date of event
- 31 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"MANGROVE PARTNERS IM, LLC disclosed 6.2% ownership in Anebulo Pharmaceuticals, Inc. Common Stock (ANEB) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 17 Mar 2025, 16:51.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Mangrove Partners IM, LLC | 6.2% | 2,525,252 | 0 | 2,525,252 | Nathaniel August | Nathaniel August, President | |
| Nathaniel August | 6.2% | 2,525,252 | 0 | 2,525,252 | Nathaniel August | Nathaniel August |